These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 35386658)

  • 41. Human rhinovirus models in asthma.
    Singh AM; Busse WW
    Contrib Microbiol; 2007; 14():12-20. PubMed ID: 17684329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of omalizumab on markers of inflammation in patients with allergic asthma.
    Holgate S; Smith N; Massanari M; Jimenez P
    Allergy; 2009 Dec; 64(12):1728-36. PubMed ID: 19839977
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.
    Busse W; Corren J; Lanier BQ; McAlary M; Fowler-Taylor A; Cioppa GD; van As A; Gupta N
    J Allergy Clin Immunol; 2001 Aug; 108(2):184-90. PubMed ID: 11496232
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisal.
    Burch J; Griffin S; McKenna C; Walker S; Paton J; Wright K; Woolacott N
    Pharmacoeconomics; 2012 Nov; 30(11):991-1004. PubMed ID: 22950547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation.
    Beale J; Jayaraman A; Jackson DJ; Macintyre JDR; Edwards MR; Walton RP; Zhu J; Man Ching Y; Shamji B; Edwards M; Westwick J; Cousins DJ; Yi Hwang Y; McKenzie A; Johnston SL; Bartlett NW
    Sci Transl Med; 2014 Oct; 6(256):256ra134. PubMed ID: 25273095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Persistence of rhinovirus RNA after asthma exacerbation in children.
    Kling S; Donninger H; Williams Z; Vermeulen J; Weinberg E; Latiff K; Ghildyal R; Bardin P
    Clin Exp Allergy; 2005 May; 35(5):672-8. PubMed ID: 15898992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microarray Technology May Reveal the Contribution of Allergen Exposure and Rhinovirus Infections as Possible Triggers for Acute Wheezing Attacks in Preschool Children.
    Niespodziana K; Stenberg-Hammar K; Papadopoulos NG; Focke-Tejkl M; Errhalt P; Konradsen JR; Söderhäll C; van Hage M; Hedlin G; Valenta R
    Viruses; 2021 May; 13(5):. PubMed ID: 34063445
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Study of Clinical Characteristics and Cytokine Profiles of Asthmatic Children with Rhinovirus Infection during Acute Asthma Exacerbation at National Hospital of Pediatrics.
    Nguyen-Thi-Dieu T; Le-Thi-Thu H; Le-Thi-Minh H; Pham-Nhat A; Duong-Quy S
    Can Respir J; 2018; 2018():9375967. PubMed ID: 30210646
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-IgE: lessons learned from effects on airway inflammation and asthma exacerbation.
    Fahy JV
    J Allergy Clin Immunol; 2006 Jun; 117(6):1230-2. PubMed ID: 16750979
    [TBL] [Abstract][Full Text] [Related]  

  • 50. No exacerbation but impaired anti-viral mechanisms in a rhinovirus-chronic allergic asthma mouse model.
    Rochlitzer S; Hoymann HG; Müller M; Braun A;
    Clin Sci (Lond); 2014 Jan; 126(1):55-65. PubMed ID: 23822145
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
    Nowak D
    Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Microengineered Airway Lung Chip Models Key Features of Viral-induced Exacerbation of Asthma.
    Nawroth JC; Lucchesi C; Cheng D; Shukla A; Ngyuen J; Shroff T; Varone A; Karalis K; Lee HH; Alves S; Hamilton GA; Salmon M; Villenave R
    Am J Respir Cell Mol Biol; 2020 Nov; 63(5):591-600. PubMed ID: 32706623
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Omalizumab: a recombinant humanized anti-IgE antibody for allergic asthma.
    Ruffin CG; Busch BE
    Am J Health Syst Pharm; 2004 Jul; 61(14):1449-59. PubMed ID: 15332692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Omalizumab in the management of patients with allergic (IgE-mediated) asthma.
    Sandström T
    J Asthma Allergy; 2009 May; 2():49-62. PubMed ID: 21437144
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of Rhinovirus C Bronchiolitis and Immunoglobulin E Sensitization During Infancy With Development of Recurrent Wheeze.
    Hasegawa K; Mansbach JM; Bochkov YA; Gern JE; Piedra PA; Bauer CS; Teach SJ; Wu S; Sullivan AF; Camargo CA
    JAMA Pediatr; 2019 Jun; 173(6):544-552. PubMed ID: 30933255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy predictors of omalizumab in Chinese patients with moderate-to-severe allergic asthma: Findings from a
    Li J; Wang C; Liu C; Kang J; Kong L; Huang Y; Liu S; Huang M; Wang L; Fogel R; Jaumont X; Yang J; Zhong N
    World Allergy Organ J; 2020 Dec; 13(12):100469. PubMed ID: 34611470
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lower airway rhinovirus burden and the seasonal risk of asthma exacerbation.
    Denlinger LC; Sorkness RL; Lee WM; Evans MD; Wolff MJ; Mathur SK; Crisafi GM; Gaworski KL; Pappas TE; Vrtis RF; Kelly EA; Gern JE; Jarjour NN
    Am J Respir Crit Care Med; 2011 Nov; 184(9):1007-14. PubMed ID: 21816938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.
    Katsaounou P; Buhl R; Brusselle G; Pfister P; Martínez R; Wahn U; Bousquet J
    Respir Med; 2019 Apr; 150():51-62. PubMed ID: 30961951
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Involvement and Possible Role of Eosinophils in Asthma Exacerbation.
    Nakagome K; Nagata M
    Front Immunol; 2018; 9():2220. PubMed ID: 30323811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.
    Jackson DJ; Makrinioti H; Rana BM; Shamji BW; Trujillo-Torralbo MB; Footitt J; Jerico Del-Rosario ; Telcian AG; Nikonova A; Zhu J; Aniscenko J; Gogsadze L; Bakhsoliani E; Traub S; Dhariwal J; Porter J; Hunt D; Hunt T; Hunt T; Stanciu LA; Khaitov M; Bartlett NW; Edwards MR; Kon OM; Mallia P; Papadopoulos NG; Akdis CA; Westwick J; Edwards MJ; Cousins DJ; Walton RP; Johnston SL
    Am J Respir Crit Care Med; 2014 Dec; 190(12):1373-82. PubMed ID: 25350863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.